CoChat

A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence

Open access

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Staphylococcus aureus produces hospital- and community-acquired infections, with methicillin-resistant S. aureus posing a serious public health threat. The golden carotenoid pigment of S. aureus , staphyloxanthin, promotes resistance to reactive oxygen species and host neutrophil-based killing, and early enzymatic steps in staphyloxanthin production resemble those for cholesterol biosynthesis. We determined the crystal structures of S. aureus dehydrosqualene synthase (CrtM) at 1.58 angstrom resolution, finding structural similarity to human squalene synthase (SQS). We screened nine SQS inhibitors and determined the structures of three, bound to CrtM. One, previously tested for cholesterol-lowering activity in humans, blocked staphyloxanthin biosynthesis in vitro (median inhibitory concentration ∼100 nM), resulting in colorless bacteria with increased susceptibility to killing by human blood and to innate immune clearance in a mouse infection model. This finding represents proof of principle for a virulence factor–based therapy against S. aureus .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.1153018

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 1

  1. National Research Council. Treating Infectious Diseases in a Microbial World: Report of Two Workshops on Novel Antimicrobial Therapeutics. National Academies Press; Washington, DC: 2006. pp. 21–22. [PubMed] [Google Scholar]

Cited by

Items 101–200 of 505

Metadata

Authors
Liu, C.-I., Liu, G. Y., Song, Y., Yin, F., Hensler, M. E., Jeng, W.-Y., Nizet, V., Wang, A. H.-J., & Oldfield, E.
Affiliations
Cedars-Sinai Medical Center (US)
Corresponding author
  • Liu, Chia-I
  • Liu, George Y.
  • Song, Yongcheng
  • Nizet, Victor
  • Wang, Andrew H.-J.
  • Oldfield, Eric
Venue
Science
Published
2008-03-07
Volume
319
Issue
5868
Pages
1391-1394
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W1986930831
Cited by
490
References
16
Citations by year
2026: 16 · 2025: 28 · 2024: 34 · 2023: 26 · 2022: 24 · 2021: 25 · 2020: 28 · 2019: 31 · 2018: 28 · 2017: 40 · 2016: 23 · 2015: 17 · 2014: 32 · 2013: 26 · 2012: 33
FWCI
17.57
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of General Medical Sciences (R01GM065307, GM073216, R01GM073216, GM65307)
  • National Institute of Allergy and Infectious Diseases (AI07482)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 051796, R01HD051796)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Microbial Metabolism and Applications
Keywords
Staphylococcus aureus, cholesterol synthesis inhibition, CRTM, squalene synthase inhibitors, methicillin-resistant Staphylococcus aureus, bacterial virulence, reactive oxygen species resistance, crystal structure
MeSH terms
Amino Acid Sequence, Animals, Anti-Bacterial Agents, Bacterial Proteins, Cell Line, Cholesterol, Enzyme Inhibitors, Humans, Molecular Sequence Data, Organothiophosphorus Compounds, Polyisoprenyl Phosphates, Sesquiterpenes, Farnesyl-Diphosphate Farnesyltransferase, Staphylococcal Infections, Staphylococcus aureus, Virulence, Protein Structure, Secondary, Crystallography, X-Ray, Xanthophylls, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.